Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

Medicare has negotiated list price reductions of up to 85% for 15 widely used drugs in the program, including Novo Nordisk's ...

Ten widely prescribed and expensive medications used by millions of Americans on Medicare to treat blood clots, cancer, heart disease and diabetes such as Xarelto, Eliquis and Jardiance will be ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The list of drugs seeing a price cut for Medicare recipients is increasing — some cancer meds are set to drop by thousands.

Ten widely prescribed and expensive medications used by millions of Americans on Medicare to treat blood clots, cancer, heart disease and diabetes will be getting a lot cheaper, according to an ...

The rising cost of prescription drugs has been a significant concern for many Americans, especially those who lack adequate insurance coverage. With prices for common medications often reaching ...

According to a review in the Annals of Internal Medicine, 20 to 30 percent of medication prescriptions are never filled, and approximately 50 percent of medications for chronic disease are not taken ...

President Donald Trump signed an executive order that aims to lower the costs of prescription drugs. The order calls for lowering the costs of life-saving drugs for low-income patients. Some experts ...